Other studies have shown that high CSF2RB expression is associated with an unfavorable prognosis in bladder and esophageal cancers, whereas it is related to a favorable prognosis in breast cancer, cervical squamous cell carcinoma and endo-cervical adenocarcinoma (CESC), and colon adenocarcinoma (Huang et al., 2020). This evidence concerns the gene CSF2RB and breast carcinoma.